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Newcastle disease virus (NDV) is an economically important avian virus that causes 
loss to the poultry industry. It has a wide host range infecting 27 of the 50 orders of 
birds. Generally, the virus consists of six structural proteins: nucleocapsid (NP), 
phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuramidase (HN) and 
large (L). The NP protein resembles the classical herringbone morphology when 
observed under electron microscope. However, the morphology changed into 
individual ring-like particles when the myc epitope and six histidine residues were 
fused to the C-terminal end of the protein. Further investigation showed that the C-
terminus of this protein derivative is exposed on the surface of the ring-like 
particles. In this project, several chimeric proteins have been constructed in which 
the antigenic regions of the HN or F protein of NDV strain AF2240, myc epitope 
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and six histidine residues were linked to the C-tenninus of the NP protein. The 
chimeric proteins were expressed efficiently in Escherichia coli as detected by 
Western blot analysis. Electron microscopic analysis on these proteins revealed that 
they assembled into ring-like particles. These chimeric NP proteins exhibited 
antigenicity of the myc epitope suggesting that the foreign sequences were exposed 
on the surface of the particles. Chickens vaccinated with the chimeric particles 
exhibited an immune response against NDY. However, no protection was observed 
when the vaccinated chickens were challenged by the virus. 
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Virus penyakit Newcastle (NDV) merupakan virus avian yang penting yang 
menyebabkan kerugian terhadap perusahaan pentemakan ayam. Virus ini 
mempunyai hos yang luas serta berupaya untuk mengjangkiti 27 daripada 50 order 
burung. Secara amnya, virus ini mempunyai enam jenis protein: nucleocapsid (NP), 
phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuramidase (HN) dan 
large (L). Pemerhatian di bawah mikroskop elektron menunjukkan protein NP bagi 
virus ini bergabung membentuk morfologi tulang 'herring'. Walaubagaimanapun, 
morfologi ini berubah menjadi bentuk gegelang individu apabila epitop myc dan 
enam residu histidina dicantumkan kepada tenninal-C protein tersebut. Kajian 
seterusnya mendapati tenninal-C ini mengunjur keluar dari pennukaan bentuk 
gegelang tersebut. Di dalam projek ini, beberapa protein 'chimeric' yang 
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mengandungi protein NP telah dibentuk dengan menggabungkan beberapa bahagian 
antigen dari protein HN atau F, epitop myc dan histidina residu ke terminal-C 
protein itu. Protein 'chimeric' ini telah betjaya diekspres dalam Escherichia coli dan 
boleh dikesan dengan pemblotan Western. Pengamatan dengan menggunakan 
mikroskop elecktron menunjukkan protein 'chimeric' ini juga membentuk gegelang 
individu itu. Kajian terhadap sifat antigen menunjukkan epitop myc pada protein ini 
dapat dikesan dengan antibodi. Ini mencadangkan protein yang digabungkan 
terdedah pada permukaan gegelang tersebut. Selain itu, ayam-ayam yang disuntik 
dengan protein • chimeric' ini dapat mengbasilkan antibodi terhadap virus penyakit 
Newcastle. Walaubagaimanapun, ayam-ayam ini tidak dapat dilindungi daripada 
jangkitan penyakit Newcastle ini. 
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CHAPTER 1 
INTRODUCTION 
Newcastle disease (ND) is a major disease that can cause huge losses to the 
poultry industries. The disease is caused by the Newcastle disease virus (NDV). Other 
diseases that threaten the industries are infectious bursal disease, influenza A, infectious 
bronchitis disease and Marek's disease. ND is controlled by using vaccines. This method 
of control is effective, reliable and has been used for quite a long time (Hilgers el at., 
1998). 
There are several forms of vaccines used in controlling ND. The most widely 
used are the live and killed vaccines. These vaccines are usually made from the 
lentogenic viruses which do not cause any illness to the adult chicken. The strains of 
NDV that are usually used as vaccines are La Sota (Goldhaft, 1980), Mustekwar, 
Clone30 and B 1 (Hitchner and Johnson, 1948). These vaccines are not only cheap but 
they can provide sufficient protection to the chicken against the virus. The vaccines are 
delivered through several ways. For example, the killed vaccines are usually delivered 
through injections. Simpler routes of vaccination are applied for the live vaccines. These 
vaccines are usually delivered orally, through aerosol, eye drop, piercing and even vent 
brush (GalliIi and Nathan, 1998). 
Even though the live and killed ND vaccines are successful and widely utilized 
around the world, studies are being conducted to enhance their efficiency and quality of 
these vaccines (Maas et aI., 1999). Such studies were carried out to improve numerous 
aspects of the vaccines such as the routes and doses of vaccination given to the chicken as 
well as production cost. The efficiency of most of the vaccines can be enhanced by 
delivering them with adjuvants. These adjuvants, however, must be safe and cheap. 
Examples of adjuvants normally used in the vaccination are oil emulsion and 
lipopolysaccharides (Hilgers et aI., 1998� Aucouturier et aI., 2001). Even though these 
live vaccines are effective, its safety is of high concern, due to the sporadic ND outbreak 
in Australia within vaccinated chicken flocks and also at locations near them. These 
outbreaks were often found to be caused by new isolates that originated from the 
lentogenic viruses (Gould et aI., 2001). 
In order to improve these problems, the potential of using genetically engineered 
vaccines in controlling ND and other poultry diseases have been carried out. The 
vaccines involved in such studies are usually proteins as well as DNA. Sakaguchi et al. 
(1996) constructed a plasmid expressing the fusion (F) protein of NDV capable of 
inducing protective immunity when injected into chickens. Several recombinant vaccines 
have also been developed that provide protection against ND. Poxvirus-type vectors such 
as vaccinia (Meulemans et al., 1988a; Nishino et al., 1991), fowlpox (Boursnell et al., 
1990) and pigeon pox (Letellier et aI., 1991) expressing either the F or haemagglutinin­
neuramidase (RN) proteins have been shown to be protective. In addition, a chimeric 
herpes virus of turkeys expressing the F and RN of NDV is protective against both 
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Marek's disease and NO (Morgan e( (1t., 1992; Hecket et (1/., 1996; Reddy ef (1/., (996). 
Most of these vaccines, which were developed for ND and other chicken diseases, 
reduced the vaccination time, cost and stress put on the chicken. Besides, there are 
research on the use of carriers to produce vaccines. The carriers can be fused to obtain 
chimeric antigens, possessing desired properties derived from the fusion partner which 
are added to the target antigen (LaVallie and McCoy, 1995; Nilsson et aI., 1997). The 
main objectives of using carriers are to simplify the production and purification of the 
recombinant vaccines (Nygren el al., 1994). 
Recently, the nucleocapsid (NP) protein of NOV was successfully obtained by 
expressing it in bacterial system (Kho et aI., 2001). The derivative of this NP protein, 
NPcfus, which contains the myc epitope and six histidine residues fused to the C·tenninus, 
was expressed in the same system. These fusion proteins were expressed in abundance as 
highly soluble and stable proteins which can be purified easily by sucrose gradient 
centrifugation. Both the NP and NPcfus proteins self-assembled into ring-like particles. 
However, the NPcfus did not form the herringbone-like structure as the NP protein, 
suggesting that the fusion of the myc epitope and histidine residues inhibited the 
herringbone-like particles formation. Further examination by immunogold labelling on 
the NPcfus particles revealed that its C-terminus is exposed on the surface of the ring-like 
particles (Kho et aI., 2001). 
Based on the above finding, it is obvious that the NP cfus has the potential to be 
developed as a carrier for chimeric antigens. This protein has all the criteria needed to 
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hecome such a carrier. In addition, this protein is stable and its C-tenninus is exposed on 
the surface of the protein, thus It is ideal for carrying any ant igen. 
Therefore, the objectives of this research were: 
1. to investigate the potential of NP cfus as an antigen carrier by fusing the epitopes of 
HN or F glycoproteins to the C-tenninus ofNPcfus; 
2. to evaluate the capability of these chimeric NP proteins in inducing immune 
response in chickens; and 
3. to detennine whether the antibodies induced by such chimeric NP proteins can 
induce protection against NDV. 
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Chapter 2 
Literature Review 
Newcastle disease (NO) is a very contagious disease which causes the 
loss of million Ringgit Malaysia every year (Kho et af., 1999). ND is caused by 
Newcastle disease virus (NOV). The virus is classified as a member of the order 
MononegaviraJes, family Paramyxoviridae, subfamily Paramyxovirinae (Seal et 
ai, 2000a; Yusoff and Tan, 2001). Initially, NOV was classified as the prototype 
of Paramyxovirus, but it was later classified as the member of RubuJaviruses in 
1993 (Yusoff and Tan, 2001; Gould et aJ, 2001). In general, other members of 
the Rubulaviruses contain small hydrophobic (SH) gene which is deficient in 
NOV (Lamb and Kolakofsky, 1996) and based on this dissimilarity, it has been 
suggested that NOV be grouped as a separate member of Paramyxovirinae (de 
Leeuw and Peeters, 1999). NOV not only can infect chickens but it is known to 
be infectious to other types of birds such as turkey pigeon, ostrich and wild bird 
(Alexander, 1989; Samina et aI., 1999). Therefore, the virus has a broad range of 
host or reservoirs that can make it spread rapidly. Generally, chickens are the 
most susceptible to NOV infection compare to other avian species. 
2.1. Occurrence ofNDV 
ND was first discovered in Jakarta, Indonesia in 1926. However, the first 
outbreak was reported by Doyle in Newcastle-Upon-Tyne during spring 1926 
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(Seal et ai., 2000a). Subsequently, more outbreaks were reported in several 
countries such as Philiphines, Korea, Sri Lanka and India (Alexander, 1988). 
Eventhough ND was only noticed in 1926, it was not a totally new disease. The 
emergence of the disease is believed to occur earlier than the first reported 
outbreak, but the occurrences were disregarded due to the lack of expertise in the 
disease and diagnostic tools for detection. Moreover, ND nonnally occurs along 
with other avian diseases making identification very difficult (Alexander, 1988). 
Since then, several techniques have been employed to overcome the disease and 
these were successful in its control. Nowadays, outbreaks of ND still occur 
worldwide, but these can be detected rapidly by various reliable methods such as 
polymerase chain reactions (peR) and ELISA (Errington et al., 1995� Makkay el 
a/., 1999). 
2. 2. Pathotypes and the Importance 
NOV can be divided according to their pathogenicity. The virus is mainly 
divided into three pathotypes (Gallili and Nathan, 1998; Romer-Obendorfer et 
a/., 1999). Viruses that cause severe disease and lOOOA. mortality are termed 
velogenic strains. The velogenic strains are further separated into two subgroups 
namely, viscerostropic strains that induce haemorrhagic intestinal lesions, and 
the neurotropic strains that are responsible for acute respiratOlY and nervous 
disorders (Alexander 1989; Gallili and Nathan, 1998). The strain that causes 
moderate disease but seriously reduce the egg production are termed mesogenic 
(Peeters el aJ., 2001). The strains normally cause only 50% mortality. The strains 
of low virulence are tenned lentogenic which presents extremely low mortality 
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except for young chicks, where it can still cause deaths. The differences of these 
strains can be observed by mean death time (MDT), intracerebral pathogenicity 
index (ICPI) and intravenous pathogenicity index (lVPI) (GaiJili and Nathan, 
1998). Velogenic strains have an lePI and IVPI ranging from 1.5 to 3.0 units, 
whereas mesogenic and lentogenic have an ICPI and IVPI values less than 1.0 
unit. The differences are also observed on their mean time required to kill an 
embryonated egg (MDT). MDT for velogenic strains was less than 60 h. In 
contrast, MDT for lentogenic is more than 90 h, and for velogenic, the MDT is 
between 60 to 90 h (Alexander, 1989; Gallili and Nathan, 1998). These 
differences between the pathogenicity of these strains are shown in Table 2.1. 
The pathogenicity is essential to identify the mode of actions of the virus 
because virus mortality is strain dependent. Furthermore, the virus has a broad 
host range, which can easily and rapidly transmit. The incubation period of the 
virus is less than a week. Birds may die without showing any clinical signs 
especially when infected with velogenic strains. Some of the birds may show 
gasping, muscular tremors, spasms, and even paralysis upon infections 
(Sakaguchi et al., 1996). In the infection of the mesogenic strains, respiratory 
illness may dominate the clinical signs at the early phase. Later on, egg 
production falls dramatically. In the case of infection by lentogenic strains 
towards adult birds, no severe disease can be observed (Reynolds and Maraqa, 
20ooa). NDV is vel)' infectious and chickens are usually vel)' susceptible to the 
infection. Therefore, chickens can easily be infected and the infection with 
various strains ofNDV not only kills them but also affects the egg production. 
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